Terapija Alzheimerove bolesti: sadašnjost i budućnost

Professional paper - Professional paper

• Author: Sara Šipicki
• Author: Zrinka Rajić Džolić
• Author's institution: University of Zagreb; Faculty of Pharmacy and Biochemistry; (Department of medicinal chemistry)
• Scientific / art field, discipline and subdiscipline: BIOMEDICINE AND HEALTHCARE; Pharmacy; Pharmacy

Abstract (english)

Alzheimer's disease is one of the most prevalent dementia, known since the
beginning of the 20th century, women being more affected with it. Here we describe
the pathophysiology and clinical picture of the disease and give an overview of the
current therapeutic options. There are only four drugs, divided in two classes, registered
for the therapy of Alzheimer's disease. Non of the existing drugs are able to stop
the progression of the disesase, so we also take a look into the future with hope that
the efficient drug to cure Alzheimer's disease will soon see the light of the day.

• Keywords (croatian): Alzheimerova bolest; inhibitori acetilkolinesteraze; antagonisti NMDA receptora
• Language: croatian
• Publication type: Professional paper - Professional paper
• Publication status: Published
• Peer review: Peer review - domestic
• Publication version: Published version
• Journal title: Farmaceutski glasnik
• Numbering: vol. 73, no. 9, pp. 603-612
• p-ISSN: 0014-8202
• URN:NBN: urn:nbn:hr:163:938943
• Publication: 2017
• Type of resource: Text
• Access conditions: Open access
• Created on: 2020-06-19 12:01:17